Cargando…
Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without
Cell entry of the pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mediated by its spike protein S. As a main antigenic determinant, S protein is in focus of various therapeutic strategies. Besides particle-cell fusion, S mediates fusion between infected and uninfected cells...
Autores principales: | Theuerkauf, Samuel A., Michels, Alexander, Riechert, Vanessa, Maier, Thorsten J., Flory, Egbert, Cichutek, Klaus, Buchholz, Christian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871100/ https://www.ncbi.nlm.nih.gov/pubmed/33585805 http://dx.doi.org/10.1016/j.isci.2021.102170 |
Ejemplares similares
-
Fusoselect: cell–cell fusion activity engineered by directed evolution of a retroviral glycoprotein
por: Merten, Christoph A., et al.
Publicado: (2006) -
FcγRIIA-specific DARPins as novel tools in blood cell analysis and platelet aggregation
por: Riechert, Vanessa, et al.
Publicado: (2023) -
A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and Vaccination
por: Abdul, Fabien, et al.
Publicado: (2022) -
Sp1 and Sp3 regulate basal transcription of the human APOBEC3G gene
por: Muckenfuss, Heide, et al.
Publicado: (2007) -
Minimally Invasive Anterior Cervical Discectomy Without Fusion to Treat Cervical Disc Herniations in Patients with Previous Cervical Fusions
por: Jacobson, Robert E, et al.
Publicado: (2017)